Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery
Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas disease (CD), which mostly affects underprivileged populations in South and Central America. The current standard of care for this disease are the two empirically discovered drugs benznidazole and nifurtimox. They show low efficacy, diffi...
Shranjeno v:
Glavni avtor: | |
---|---|
Drugi avtorji: | |
Format: | Dissertation |
Jezik: | angleščina |
Izdano: |
Philipps-Universität Marburg
2019
|
Teme: | |
Online dostop: | PDF-Volltext |
Oznake: |
Označite
Brez oznak, prvi označite!
|
Komentirajte kot prvi!